Animal drug company Eco Animal Health said it had received a positive opinion from the European Medicines Agency for the use of Aivlosin water-soluble granules for the treatment of Mycoplasma hyopneumoniae in pigs. Mycoplasma hyopneumoniae was the most common primary pathogen in pig respiratory disease and a key instigator of secondary bacterial and viral pathogens. Aivlosin, an antimicrobial, was used under veterinary prescription for the treatment of a variety of economically important respiratory and enteric diseases in poultry and pigs. The European Commission as expected to issue a marketing authorisation within two months of the publication of a positive opinion, the company said. At 1:27pm: (LON:EAH) Eco Animal Health Group PLC share price was +10.5p at 208p
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.